Mark Rubinstein to Antibodies, Viral
This is a "connection" page, showing publications Mark Rubinstein has written about Antibodies, Viral.
Connection Strength
0.383
-
Selective suppression of de novo SARS-CoV-2 vaccine antibody responses in patients with cancer on B cell-targeted therapy. JCI Insight. 2023 Mar 22; 8(6).
Score: 0.199
-
COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer. Cancer Cell. 2022 02 14; 40(2):117-119.
Score: 0.183